Patients Infected with CRF07_BC Have Significantly Lower Viral Loads than Patients with HIV-1 Subtype B: Mechanism and Impact on Disease Progression

A Vasan, 2006, Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype, Clin Infect Dis, 42, 843, 10.1086/499952

JM Baeten, 2007, HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads, J Infect Dis, 195, 1177, 10.1086/512682

R Rangsin, 2007, The natural history of HIV-1 subtype E infection in young men in Thailand with up to 14 years of follow-up, AIDS, 21, S39, 10.1097/01.aids.0000299409.29528.23

N Pant Pai, 2012, Does genetic diversity of HIV-1 non-B subtypes differentially impact disease progression in treatment-naive HIV-1-infected individuals? A systematic review of evidence: 1996-2010, J Acquir Immune Defic Syndr, 59, 382, 10.1097/QAI.0b013e31824a0628

(2013) Center for Disease Control, ROC (Taiwan). HIV/AIDS data.

YM Chen, 2001, Temporal trends and molecular epidemiology of HIV-1 infection in Taiwan from 1988 to 1998, J Acquir Immune Defic Syndr, 26, 274, 10.1097/00126334-200103010-00011

YM Chen, 2006, HIV-1 CRF07_BC infections, injecting drug users, Taiwan, Emerg Infect Dis, 12, 703, 10.3201/eid1204.050762

YT Lin, 2007, Molecular epidemiology of HIV-1 infection and full-length genomic analysis of circulating recombinant form 07_BC strains from injection drug users in Taiwan, J Infect Dis, 195, 1283, 10.1086/513437

YM Chen, 2007, HIV-1 in Taiwan, Lancet, 369, 623, 10.1016/S0140-6736(07)60291-8

YJ Chen, 2012, Molecular epidemiology of HIV-1 infection in Taiwan from 2005 to 2008: further spread of CRF07_BC and emergence of CRF07_BC/subtype B dual infection, J Acquir Immune Defic Syndr, 59, 438, 10.1097/QAI.0b013e3182454ea3

UM Munshi, 2007, An Alix fragment potently inhibits HIV-1 budding: characterization of binding to retroviral YPXL late domains, J Biol Chem, 282, 3847, 10.1074/jbc.M607489200

B Strack, 2003, AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding, Cell, 114, 689, 10.1016/S0092-8674(03)00653-6

J Zhou, 2005, The TREAT Asia HIV Observational Database: baseline and retrospective data, J Acquir Immune Defic Syndr, 38, 174, 10.1097/01.qai.0000145351.96815.d5

M Wei, 2004, Simple subtyping assay for human immunodeficiency virus type 1 subtypes B, C, CRF01-AE, CRF07-BC, and CRF08-BC, J Clin Microbiol, 42, 4261, 10.1128/JCM.42.9.4261-4267.2004

X Xin, 1998, Facilitation of HIV-1 isolation from patients by neuraminidase, Arch Virol, 143, 85, 10.1007/s007050050270

A Trkola, 1998, Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines, J Virol, 72, 396, 10.1128/JVI.72.1.396-404.1998

A Karlsson, 1994, MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection, J Clin Microbiol, 32, 364, 10.1128/JCM.32.2.364-370.1994

RA Fouchier, 1992, Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule, J Virol, 66, 3183, 10.1128/JVI.66.5.3183-3187.1992

T Shioda, 1992, Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1, Proc Natl Acad Sci U S A, 89, 9434, 10.1073/pnas.89.20.9434

T Cardozo, 2007, Structural basis for coreceptor selectivity by the HIV type 1 V3 loop, AIDS Res Hum Retroviruses, 23, 415, 10.1089/aid.2006.0130

Z Hu, 2006, Fitness comparison of thymidine analog resistance pathways in human immunodeficiency virus type 1, J Virol, 80, 7020, 10.1128/JVI.02747-05

HC Chiu, 2006, Effects of human immunodeficiency virus type 1 transframe protein p6* mutations on viral protease-mediated Gag processing, J Gen Virol, 87, 2041, 10.1099/vir.0.81601-0

K Toohey, 1995, Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread, Virology, 213, 70, 10.1006/viro.1995.1547

AL Ferris, 1990, Immunologic and proteolytic analysis of HIV-1 reverse transcriptase structure, Virology, 175, 456, 10.1016/0042-6822(90)90430-Y

A Hachiya, 2001, Rapid and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4(+) cell clone 1-10 (MAGIC-5), Antimicrob Agents Chemother, 45, 495, 10.1128/AAC.45.2.495-501.2001

F Spira, 2012, Patchwork organization of the yeast plasma membrane into numerous coexisting domains, Nat Cell Biol, 14, 640, 10.1038/ncb2487

Manders EMM, Verbeek FJ, Aten JA (1993) Measurement of co-localization of objects in dual-colour confocal images. Journal of Microscopy. pp. 8.

DJ Hu, 2001, Viral load differences in early infection with two HIV-1 subtypes, AIDS, 15, 683, 10.1097/00002030-200104130-00003

K Zhao, 2014, Genotypes and Transmitted Drug Resistance among Treatment-Naive HIV-1-Infected Patients in a Northwestern Province, China: Trends from 2003 to 2013, PLoS One, 9, e109821, 10.1371/journal.pone.0109821

SL Zeger, 1988, Models for longitudinal data: a generalized estimating equation approach, Biometrics, 44, 1049, 10.2307/2531734

DN Raugi, 2013, HIV-1 outcompetes HIV-2 in dually infected Senegalese individuals with low CD4(+) cell counts, AIDS, 27, 2441, 10.1097/QAD.0b013e328362e856

W Kittikraisak, 2009, Blood and seminal plasma HIV-1 RNA levels among HIV-1-infected injecting drug users participating in the AIDSVAX B/E efficacy trial in Bangkok, Thailand, J Acquir Immune Defic Syndr, 51, 601, 10.1097/QAI.0b013e3181a44700

CS Morrison, 2010, Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection, AIDS, 24, 573, 10.1097/QAD.0b013e32833433df

M Gandhi, 2002, Does patient sex affect human immunodeficiency virus levels?, Clin Infect Dis, 35, 313, 10.1086/341249

F Nakagawa, 2014, Factors associated with short-term changes in HIV viral load and CD4+ cell count in antiretroviral-naive individuals, AIDS, 28, 1351, 10.1097/QAD.0000000000000224

G Pantaleo, 1996, Immunopathogenesis of HIV infection, Annu Rev Microbiol, 50, 825, 10.1146/annurev.micro.50.1.825

C Tscherning, 1998, Differences in chemokine coreceptor usage between genetic subtypes of HIV-1, Virology, 241, 181, 10.1006/viro.1997.8980

JW Mellors, 1996, Prognosis in HIV-1 infection predicted by the quantity of virus in plasma, Science, 272, 1167, 10.1126/science.272.5265.1167

J Weber, 2006, HIV type 1 tropism and inhibitors of viral entry: clinical implications, AIDS Rev, 8, 60

SC Ball, 2003, Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C, J Virol, 77, 1021, 10.1128/JVI.77.2.1021-1038.2003

YH Song, 2007, Analysis of HIV-1 CRF07_BC gag p6 sequences indicating novel deletions in the central region of p6, Arch Virol, 152, 1553, 10.1007/s00705-007-0973-6

SW Chen, 2004, The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particles, Virology, 318, 534, 10.1016/j.virol.2003.08.043

K Fujii, 2009, Functional role of Alix in HIV-1 replication, Virology, 391, 284, 10.1016/j.virol.2009.06.016

JH Hurley, 2010, Membrane budding and scission by the ESCRT machinery: it's all in the neck, Nat Rev Mol Cell Biol, 11, 556, 10.1038/nrm2937

T Jacks, 1988, Characterization of ribosomal frameshifting in HIV-1 gag-pol expression, Nature, 331, 280, 10.1038/331280a0

K Partin, 1990, Mutational analysis of a native substrate of the human immunodeficiency virus type 1 proteinase, J Virol, 64, 3938, 10.1128/JVI.64.8.3938-3947.1990

K Partin, 1991, Deletion of sequences upstream of the proteinase improves the proteolytic processing of human immunodeficiency virus type 1, Proc Natl Acad Sci U S A, 88, 4776, 10.1073/pnas.88.11.4776

XF Yu, 1998, Mutations of the human immunodeficiency virus type 1 p6Gag domain result in reduced retention of Pol proteins during virus assembly, J Virol, 72, 3412, 10.1128/JVI.72.4.3412-3417.1998